Drug research

OMS906 study drug

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as OMS906

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Long-Term Safety, Tolerability and Efficacy of OMS906 in Paroxysmal Nocturnal HemoglobinuriaNCT06298955	Omeros Corporation	Phase 2	Active not recruiting	2026-12Estimated
Safety and Efficacy Study of OMS906 in Patients With C3G and ICGNNCT06209736	Omeros Corporation	Phase 2	Recruiting	2026-01Estimated

Omeros CorporationActive not recruitingPrimary completion: 2026-12 · Estimated

Trial details

Omeros CorporationRecruitingPrimary completion: 2026-01 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.